Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

被引:32
作者
Gressier, L. [1 ]
Pruvost-Balland, C. [1 ]
Dubertret, L. [1 ]
Viguier, M. [1 ]
机构
[1] Univ Paris 07, Hop St Louis, Serv Dermatol, F-75475 Paris 10, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2009年 / 136卷 / 01期
关键词
Atorvastatin; Statin; Drug reaction; DRESS; INDUCED HYPERSENSITIVITY SYNDROME; REACTIVATION; ASSOCIATION;
D O I
10.1016/j.annder.2008.07.063
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - Atorvastatin is a widely-used therapeutic statin given for hypercholesterolaemia and for prevention of cardiovascular events. We report herein the occurrence of a drug reaction with eosinophilia and systemic symptoms (DRESS) secondary to intake of this drug. Case report. - A 58-year-otd woman presented with a febrile skin rash and facial oedema, appearing 6 weeks after the start of atorvastatin for dyslipidaemia. The clinical features associated disseminated polymorphic lesions, oral mucosa involvement and systemic symptoms (fever, abdominal pain, diarrhoea, polyarthralgia and adenomegaly). Blood tests showed hypereosinophilia up to 11,540/mm(3), inflammatory syndrome and anicteric cholestasis without cytolysis. Serological tests for hepatitis B and C, HIV, EBV, HHV-6, HHV-8, CMV and human Parvovirus B-19 were negative. Cutaneous histology was unspecific. A diagnosis of DRESS secondary to atorvastatin was suspected. The clinical outcome was favourable after atorvastatin discontinuation. Discussion. - To our knowledge, this is the first description of atorvastatin inducing DRESS, a severe life-threatening drug eruption. Atorvastatin has previously been implicated in various cutaneous adverse events. Because of their potentially serious side effects, prescription of statins must be carefully evaluated. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:50 / 53
页数:4
相关论文
共 19 条
[1]  
Adcock B B, 2001, J Am Board Fam Pract, V14, P148
[2]   Chronic urticaria to atorvastatin [J].
Anliker, MD ;
Wüthrich, B .
ALLERGY, 2002, 57 (04) :366-366
[3]   Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events [J].
Arca, Marcello ;
Gaspardone, Achille .
DRUGS, 2007, 67 (Suppl 1) :29-42
[4]  
BEGAUD B, 1985, THERAPIE, V40, P111
[5]   Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[6]   Atorvastatin associated liver disease [J].
Clarke, A. T. ;
Mills, P. R. .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (10) :772-777
[7]  
Descamps V, 2001, ARCH DERMATOL, V137, P301
[8]   Hypotension and eosinophilia with atorvastatin [J].
Hampson, JP ;
Smith, D ;
Cowell, R ;
Baker, A .
PHARMACY WORLD & SCIENCE, 2005, 27 (04) :279-280
[9]   Linear IgA bullous dermatosis induced by atorvastatin [J].
König, C ;
Eickert, A ;
Scharfetter-Kochanek, K ;
Krieg, T ;
Hunzelmann, N .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (04) :689-692
[10]   UV-B phototoxic effects induced by atorvastatin [J].
Marguery, Marie-Claude ;
Chouini-Lalanne, Nadia ;
Drugeon, Charlotte ;
Gadroy, Agnes ;
Bayle, Paule ;
Journe, Fabienne ;
Bazex, Jacques ;
D'Incan, Michel .
ARCHIVES OF DERMATOLOGY, 2006, 142 (08) :1082-1084